Lab (Specimen)

Conventional Units

SI Units

Haptoglobin (serum) top of page 43 – 212 mg/dL 0.43 – 2.12 g/L
Hematocrit (Hct)  Blood
top of page
Male: 41 – 50 %
Female: 35 – 46%
 
Hemoglobin (Hb) Blood top of page Male: 13.8 – 17.2 g/dL
Female: 12 – 15.6 g/dL
Male: 138 – 172 g/L
Female: 120 – 156 g/L
Hemoglobin A1c (HbA1c) Blood
top of page
<6% of total Hb
AACE Guidelines (2011)
Hemoglobin A1c, % (as a screening test)
≤5.4 – Normal
————————-
5.5-6.4 – High risk/prediabetes; requires screening by glucose criteria
————————-
≥6.5 -Diabetes, confirmed by repeating the test on a different day
=================
In general, therapy should target a A1C level of 6.5% or less for most nonpregnant adults.
<0.06 of total Hb
High density lipoprotein  cholesterol (HDL) Serum top of page >/= 35 mg/dL
Negative risk factor:
    >/= 60 mg/dL
>/= 0.9 mmol/L
Negative risk factor:
    >/= 1.55 mmol/L
Homocysteine (plasma)
top of page

6.1 – 15.0 µmol/L
Alt:
Male: 4-12 µmol/L
Female: 4-10 µmol/L
6.1 – 15.0 µmol/L
Alt:
Male: 4-12 µmol/L
Female: 4-10 µmol/L
Human chorionic gonadotropin (hCG) Qualitative (urine) top of page Nonpregnant: Negative.
Pregnant: positive
 
Human chorionic gonadotropin (hCG) Quantitative (intact and free) Serum

top of page

Male: < 2 IU/L
Premenopausal: < 5 IU/L
Postmenopausal: < 10 IU/L
Pregnancy:
0 – 2 wk: < 500 IU/L
2 – 3 wk: 100 – 5,000 IU/L
3 – 4 wk: 500 – 10,000 IU/L
1 – 2 mo: 1,000 – 200,000 IU/L
2-3 mo: 10,000 – 100,000 IU/L
Male: < 2 IU/L
Premenopausal: < 5 IU/L
Postmenopausal: < 10 IU/L
Pregnancy:
0 – 2 wk: < 500 IU/L
2 – 3 wk: 100 – 5,000 IU/L
3 – 4 wk: 500 – 10,000 IU/L
1 – 2 mo: 1,000 – 200,000 IU/L
2-3 mo: 10,000 – 100,000 IU/L
17-Hydroxycorticosteroids (urine)
top of page
Male: 3 – 15 mg/day
Female: 2 – 12 mg/day
Male: 38.3 – 41.4 µmol/day
Female: 5.5 – 33.1 µmol/day

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer